Injective, a decentralized derivatives exchange platform, will soon launch trading in tokenized stocks of major companies like Google. * Injective said Monday it would use oracle technology to provide decentralized price data for its new market and historical price data from outside traditional market hours, allowing trading around the clock. * Users

Two new synthetic asset and derivatives platforms look to take a slice of Synthetix’s pie. Synthetic assets, one of the most promising use cases for decentralized finance (DeFi), is becoming an increasingly competitive landscape as two new projects aim to bring scalability and new markets to traders. On Friday,

Decentralized exchange protocols that allow crypto traders and investors to trade across different blockсhains have been in development for a while. A significant new development now comes with the launch of the “Testnet” from Injective. Injective has been backed by Binance, one of the biggest centralized exchanges in the crypto

Injective has announced the successful public launch of the Solstice testnet, the first universal DeFi protocol for cross-chain derivatives trading. This launch marks an important milestone in the project’s mission and community to create a free and decentralized financial network for limitless trading. The project was cultivated by Binance

The Web3, or blockchain, industry, is currently in the midst of a digital transformation. We’re seeing a major push for open-source and fully decentralized products that are governed by the users themselves. While many companies claim to be truly open-source, the reality is that creating a fully frictionless and

Decentralized exchanges (DEXes) are all the rage in the present decentralized finance (DeFi) industry. These exchange markets do not rely upon a third-party service provider to hold customer funds, a major advantage over traditional exchange structures. Instead, in DEXes, funds are traded in a direct peer-to-peer (P2P) manner via automation